ZTS 8-K 2026-11-05

Zoetis Inc. (ZTS) 8-K dated 2026-11-05 — accession 0001555280-26-000048.

Zoetis Inc. (ZTS) is a drug manufacturers - specialty & generic company listed on US.

Zoetis Inc. filed a 8-K on 2026-11-05. Accession 0001555280-26-000048.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported ZTS revenue for 2025-12-31 was $9.47B. Net income was $2.67B. Revenue was up 2.3% from 2024-12-31 to 2025-12-31. ZTS currently screens at market cap $64.65B and trailing P/E 13.5.

Not investment advice. The ZTS SEC hub lists recent forms. The stock page is the research view.